×
About 2,998 results

ALLMedicine™ Allergic Conjunctivitis Center

Research & Reviews  873 results

In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in A...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140898
Drug Design, Development and Therapy; Shen T, Yang Z

May 27th, 2021 - To establish a novel delivery system of pemirolast potassium-loaded gellan gum in situ gel in allergic conjunctivitis therapy. The prepared in situ gels were studied in the following aspects: in vitro gelation, in vitro release, stability, viscosi...

Development of allergic conjunctivitis induced by Acanthamoeba excretory-secretory prot...
https://doi.org/10.1080/02713683.2021.1934878
Current Eye Research; Kang MS, JongSoo L et. al.

May 24th, 2021 - To evaluate whether allergic conjunctivitis (AC) could be induced by Acanthamoeba excretory-secretory protein (ESP) and analyze the therapeutic effect of resolvin (Rv) D1 and antiallergic agents. Human conjunctival epithelial cells (HCVCs) were tr...

The Role of Temperature Change, Ambient Temperature, and Relative Humidity in Allergic ...
https://doi.org/10.1016/j.ajo.2021.04.035
American Journal of Ophthalmology; Patel S, Kaplan C et. al.

May 15th, 2021 - Studies have implicated temperature and humidity in the pathogenesis of allergic conjunctivitis (AC), as these conditions facilitate air particulate and aeroallergen dispersion and tear film instability. Research also suggests that variation in te...

Clinically Relevant Activity of the Novel RASP Inhibitor Reproxalap in Allergic Conjunc...
https://doi.org/10.1016/j.ajo.2021.04.023
American Journal of Ophthalmology; Clark D, Cavanagh B et. al.

May 4th, 2021 - To assess the post-acute activity and clinical utility of reproxalap, a novel reactive aldehyde species (RASP) inhibitor, versus vehicle in patients with seasonal allergic conjunctivitis. Parallel-group, double-masked, randomized Phase 3 trial. Tw...

Drugs for allergic rhinitis and allergic conjunctivitis.
https://www.ncbi.nlm.nih.gov/pubmed/33848281
The Medical Letter on Drugs and Therapeutics;

Apr 13th, 2021 - Drugs for allergic rhinitis and allergic conjunctivitis.|2021||administration & dosage,pharmacology,drug therapy,administration & dosage,pharmacology,administration & dosage,pharmacology,methods,administration & dosage,pharmacology,drug therapy,

see more →

Guidelines  2 results

Conjunctivitis
https://www.aao.org/preferred-practice-pattern/conjunctivitis-ppp-2018

Nov 12th, 2018 - Evidence-based update using Cochrane Eyes and Vision Group-identified systematic reviews for the initial evaluation of conjunctivitis patients and discussion of associated or predisposing factors.

Allergic conjunctivitis: a comprehensive review of the literature
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640929/
Italian Journal of Pediatrics; La Rosa,M.,et al

Mar 13th, 2013 - Ocular allergy represents one of the most common conditions encountered by allergists and ophthalmologists. Allergic conjunctivitis is often underdiagnosed and consequently undertreated. Basic and clinical research has provided a better understand...

see more →

Drugs  587 results see all →

Clinicaltrials.gov  1,501 results

In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in A...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140898
Drug Design, Development and Therapy; Shen T, Yang Z

May 27th, 2021 - To establish a novel delivery system of pemirolast potassium-loaded gellan gum in situ gel in allergic conjunctivitis therapy. The prepared in situ gels were studied in the following aspects: in vitro gelation, in vitro release, stability, viscosi...

Development of allergic conjunctivitis induced by Acanthamoeba excretory-secretory prot...
https://doi.org/10.1080/02713683.2021.1934878
Current Eye Research; Kang MS, JongSoo L et. al.

May 24th, 2021 - To evaluate whether allergic conjunctivitis (AC) could be induced by Acanthamoeba excretory-secretory protein (ESP) and analyze the therapeutic effect of resolvin (Rv) D1 and antiallergic agents. Human conjunctival epithelial cells (HCVCs) were tr...

The Role of Temperature Change, Ambient Temperature, and Relative Humidity in Allergic ...
https://doi.org/10.1016/j.ajo.2021.04.035
American Journal of Ophthalmology; Patel S, Kaplan C et. al.

May 15th, 2021 - Studies have implicated temperature and humidity in the pathogenesis of allergic conjunctivitis (AC), as these conditions facilitate air particulate and aeroallergen dispersion and tear film instability. Research also suggests that variation in te...

Ketorolac tromethamine - ketorolac tromethamine solution-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c2290fd1-2985-1275-e053-2995a90ad5fa

May 11th, 2021 - Ketorolac tromethamine ophthalmic solution is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis. Ketorolac tromethamine ophthalmic solution is also indicated for the treatment of postoperative inflammatio...

Clinically Relevant Activity of the Novel RASP Inhibitor Reproxalap in Allergic Conjunc...
https://doi.org/10.1016/j.ajo.2021.04.023
American Journal of Ophthalmology; Clark D, Cavanagh B et. al.

May 4th, 2021 - To assess the post-acute activity and clinical utility of reproxalap, a novel reactive aldehyde species (RASP) inhibitor, versus vehicle in patients with seasonal allergic conjunctivitis. Parallel-group, double-masked, randomized Phase 3 trial. Tw...

see more →

News  33 results

PPIs, H2RAs in infants raise later allergy risk
https://www.mdedge.com/familymedicine/article/162389/neonatal-medicine/ppis-h2ras-infants-raise-later-allergy-risk/page/0/1
Pediatric News;

Apr 2nd, 2018 - The use of antibiotics in the first 6 months of life was associated with a 14% higher incidence of food allergy but with a 24% higher risk of cow’s milk allergy and egg allergy. Children prescribed antibiotics also had a twofold greater risk of as.

Tx for Allergic Conjunctivitis Falls Short: Ophthalmology Times
https://www.medpagetoday.com/ophthalmology/generalophthalmology/68445

Oct 10th, 2017 - A recent meta-analysis evaluated the risk of intraocular bleeding with newer anticoagulant medications compared with warfarin. A new survey suggests that current therapies to treat allergic conjunctivitis are inadequate. The European Commission re...

Managing MacTel: Ophthalmology Times
https://www.medpagetoday.com/ophthalmology/generalophthalmology/67131

Aug 8th, 2017 - Two physicians explore diagnosis and treatment options for the degenerative retinal condition idiopathic macular telangiectasia. How can you plan for retirement when the time is fast approaching? Experts provide advice for soon-to-be-retired physi...

The Best Tx for Fungal Keratitis: Ophthalmology Times
https://www.medpagetoday.com/ophthalmology/generalophthalmology/66295

Jun 27th, 2017 - One expert discusses the importance of improving diagnosis and treatment options for nonresponsive bacterial keratitis. A new oral formulation of itraconazole decreased tumor size in patients with basal cell carcinoma nevus syndrome, according to ...

FDA Approves Topical Antihistamine for Allergic Conjunctivitis
https://www.medpagetoday.com/ophthalmology/generalophthalmology/65684

May 30th, 2017 - The FDA has okayed cetirizine ophthalmic solution 0.24% (Zerviate), the first topical ocular formulation of this well-known antihistamine, to treat ocular itching associated with allergic conjunctivitis, the drugmaker, Nicox, announced. The drug's...

see more →

Patient Education  2 results see all →